CREDIT SUISSE AG/ - OCULAR THERAPEUTIX INC ownership

OCULAR THERAPEUTIX INC's ticker is OCUL and the CUSIP is 67576A100. A total of 151 filers reported holding OCULAR THERAPEUTIX INC in Q4 2020. The put-call ratio across all filers is 0.52 and the average weighting 0.9%.

Quarter-by-quarter ownership
CREDIT SUISSE AG/ ownership history of OCULAR THERAPEUTIX INC
ValueSharesWeighting
Q4 2022$8
-99.6%
3
-99.3%
0.00%
Q3 2022$2,000
-99.3%
440
-99.3%
0.00%
Q1 2022$302,000
-4.4%
61,043
+35.0%
0.00%
Q4 2021$316,000
-20.2%
45,202
+14.4%
0.00%
Q3 2021$396,000
-25.1%
39,510
+6.0%
0.00%
Q2 2021$529,000
-24.5%
37,277
-12.9%
0.00%
Q1 2021$701,000
-47.8%
42,797
-34.1%
0.00%
-100.0%
Q4 2020$1,344,000
+2257.9%
64,955
+349.9%
0.00%
Q1 2019$57,000
-74.8%
14,437
-57.0%
0.00%
Q2 2018$226,000
-1.7%
33,567
-5.2%
0.00%
Q1 2018$230,000
+42.9%
35,411
-2.4%
0.00%
Q4 2017$161,000
-89.4%
36,300
-85.2%
0.00%
-100.0%
Q3 2017$1,515,000
+937.7%
245,144
+1452.0%
0.00%
Q2 2017$146,000
+18.7%
15,795
+19.1%
0.00%
Q1 2017$123,000
-72.4%
13,262
-75.1%
0.00%
Q4 2016$446,000
+136.0%
53,183
+92.6%
0.00%
Q3 2016$189,000
+119.8%
27,614
+58.2%
0.00%
Q2 2016$86,000
-87.1%
17,451
-44.9%
0.00%
-100.0%
Q2 2015$667,00031,6810.00%
Other shareholders
OCULAR THERAPEUTIX INC shareholders Q4 2020
NameSharesValueWeighting ↓
SUMMER ROAD LLC 3,804,788$15,105,00043.34%
Versant Venture Management, LLC 2,215,384$8,795,074,0002.90%
Opaleye Management Inc. 1,900,000$7,543,0002.09%
SV Health Investors, LLC 628,236$2,494,0001.46%
Endurant Capital Management LP 716,124$2,843,0001.12%
DELTEC ASSET MANAGEMENT LLC 824,747$3,274,0000.72%
NOTTINGHAM ADVISORS, INC. 146,946$583,0000.08%
Jump Trading, LLC 39,255$156,0000.05%
Man Group plc 1,723,456$6,842,0000.03%
JGP Global Gestao de Recursos Ltda. 13,880$55,0000.02%
View complete list of OCULAR THERAPEUTIX INC shareholders